Lantern Pharma Inc
(NAS:LTRN)
$
2.98
-0.010 (-0.34%)
Market Cap: 38.02 Mil
Enterprise Value: 31.25 Mil
PE Ratio: 0
PB Ratio: 9.48
GF Score: 33/100 
Lantern Pharma Inc. at Benzinga Global Small Cap Conference (Virtual) Transcript
Dec 09, 2020 / 08:30PM GMT
Release Date Price:
$15.17
(-1.17%)
Patrick Lane
Benzinga - VP, Partnerships
All right, still a little ahead of schedule here; that's good. We will move right ahead to Panna Sharma from Lantern Pharma. Lantern Pharma is LTRN on the NASDAQ, LTRN, and as we are moving Panna over, there we are, I will remind everybody again if you have any questions at all for our speakers, throw them in the chat and we will be happy to moderate those along. How are you, Panna?
Panna Sharma
Lantern Pharma, Inc. - President & CEO
Great, Patrick. Thanks for having me on.
Patrick Lane
Benzinga - VP, Partnerships
It's my pleasure. I will let you jump right into it and thanks again.
Panna Sharma
Lantern Pharma, Inc. - President & CEO
Can I share my screen or is that being seen?
Patrick Lane;Panna Sharma
Benzinga - VP, Partnerships;Lantern Pharma, Inc. -
It's not being seen yet. Okay, it's coming now. One second. There, now we have it.
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
7-Day Free Trial · Cancel Anytime
Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers